Philip Huber, MD
Interventional Cardiology · Spokane, WANPI 1518971787
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $8,340 of the $9,709 with a category attached, or 85.9%. 6 manufacturers reported payments, led by Ancora Heart, Inc. at 28.5% of the total. Reporting peaked in 2024 at $4,122 and has fallen 72.8% since, to $1,123 in 2025.
Across 57 payments — averaging $170.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ancora Heart, Inc.$3K
- Edwards Lifesciences$3K
- Medtronic$2K
- Abbott$2K
- Shockwave Medical, Inc$109
- Boston Scientific$60
Across 59 payments — averaging $2724.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$81K
- Abbott$46K
- CSL Behring$18K
- Cordis Corporation$16K
What the payments were for
- Travel & lodging$8,34086%
- Food & beverage$1,36914%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ancora Heart, Inc. | 10 | $2,769 |
| Edwards Lifesciences | 16 | $2,685 |
| Medtronic(2 entities) | 11 | $2,220 |
| Abbott | 17 | $1,867 |
| Shockwave Medical, Inc | 1 | $109 |
| Boston Scientific | 2 | $60 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AccuCinch$2,590
- PASCAL$1,476
- Apollo$676
- MitraClip$152
- Vascular Lithotripsy$109
How this compares
$9,709 in reported general payments places this provider in the 65th percentile of 125 interventional cardiology providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 199 | $171,850 |
| Repatha SureclickEvolocumab | 65 | $66,638 |
| EntrestoSacubitril/Valsartan | 46 | $47,092 |
| XareltoRivaroxaban | 47 | $43,984 |
| JardianceEmpagliflozin | 39 | $30,444 |
| Praluent PenAlirocumab | 16 | $22,451 |
| Metoprolol Succinate | 242 | $3,728 |
| Atorvastatin Calcium | 261 | $3,290 |
| ClopidogrelClopidogrel Bisulfate | 191 | $2,833 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 122 | $2,186 |
| Prasugrel Hcl | 34 | $1,920 |
| Losartan Potassium | 205 | $1,742 |
| Rosuvastatin Calcium | 126 | $1,739 |
| Carvedilol | 114 | $1,484 |
| Ranolazine ErRanolazine | 19 | $1,294 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Spokane
- Mohit JainSpokane$98K
- Michael RingSpokane$47K
- Joel GallowaySpokane$12K
- Jonathan HansenSpokane$10K
- Dieter LubbeSpokane$7K
- Timothy BallSpokane$6K
- Brydan CurtisSpokane$5K
- William LombardiSeattle$902K
- Kathleen KearneySeattle$448K
- Robert RileyBellevue$431K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.